All Pharma News
Pfizer to end licence deal with Syros for blood disorder therapies

Pfizer to end licence deal with Syros for blood disorder therapies
BUSINESS TIMES
22 Jul 2023
Share Share
Global Blood Therapeutics` Oxbryta (voxelotor) Receives Approval in Europe

Global Blood Therapeutics` Oxbryta (voxelotor) Receives Approval in Europe
EMA
13 Jun 2023
Share Share
GBT and Sickle Cell Disease Association of America to Host 11th

GBT and Sickle Cell Disease Association of America to Host 11th
GLOBENEWSWIRE
08 Sep 2022
Share Share
J&J lost to Pfizer in $5.4B GBT bidding war: Bloomberg

J&J lost to Pfizer in $5.4B GBT bidding war: Bloomberg
Angus Liu FIERCEPHARMA
24 Aug 2022
Share Share
How Pfizer became interested in GBT and reached the $5.4B buy

How Pfizer became interested in GBT and reached the $5.4B buy
Angus Liu FIERCEPHARMA
23 Aug 2022
Share Share
Lilly criticizes Indiana abortion law, indicating it may look elsewhere to hire

Lilly criticizes Indiana abortion law, indicating it may look elsewhere to hire
Dellilah Alvarado BIOPHARMADIVE
09 Aug 2022
Share Share
Pfizer eyeing $5B play for Global Blood Therapeutics: WSJ

Pfizer eyeing $5B play for Global Blood Therapeutics: WSJ
Eric Sagonowsky FIERCEPHARMA
06 Aug 2022
Share Share
GBT Announces New Employment Inducement Grants

GBT Announces New Employment Inducement Grants
PRESS RELEASE
04 Aug 2022
Share Share
GBT Announces Participation at the Wedbush PacGrow Healthcare Conference

GBT Announces Participation at the Wedbush PacGrow Healthcare Conference
GLOBENEWSWIRE
03 Aug 2022
Share Share
GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022

GBT to Announce Second Quarter 2022 Financial Results on Monday, August 8, 2022
GLOBENEWSWIRE
29 Jul 2022
Share Share